Evidence map›Paper›PMID 32429902›Full record

ArticleBMC endocrine disorders2020

Serum Fetuin-A levels are increased and associated with insulin resistance in women with polycystic ovary syndrome.

Sha Liu, Wenjing Hu, Yirui He, Ling Li, Hua Liu, Lin Gao, Gangyi Yang, Xin Liao

Open access · goldAbstract read
In one paragraph

Article in BMC endocrine disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Lower Serum ATG7 Levels Linked to Insulin Resistance in Women with Polycystic Ovary Syndrome.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Insulin resistance and cardiovascular disease.The Journal of international medical research · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Sha LiuDepartment of Endocrinology, the Affiliated Hospital, Zunyi Medical University, Zunyi, 563003, Guizhou, China.
Wenjing HuChongqing Prevention and Treatment Hospital for Occupational Diseases, Chongqing, China.
Yirui HeDepartment of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Ling LiKey Laboratory of Diagnostic Medicine (Ministry of Education) and Department of Clinical Biochemistry, College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China.
Hua LiuDepartment of Pediatrics, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS, USA.
Lin GaoDepartment of Endocrinology, the Affiliated Hospital, Zunyi Medical University, Zunyi, 563003, Guizhou, China.
Gangyi YangDepartment of Endocrinology, the Affiliated Hospital, Zunyi Medical University, Zunyi, 563003, Guizhou, China. gangyiyang@163.com.
Xin LiaoDepartment of Endocrinology, the Affiliated Hospital, Zunyi Medical University, Zunyi, 563003, Guizhou, China. liaoxin8618@163.com.
Zunyi Medical University · CNChongqing Medical University · CNDalian Medical University · CNState Street (United States) · US

Funding

the National Natural Science Foundation of China 81601214
6 · The paper itself

Abstract

backgroundInsulin resistance (IR) is a common characteristic of women with polycystic ovary syndrome (PCOS). It has been reported that circulating Fetuin-A levels were associated with IR and type 2 diabetes mellitus (T2DM). However, previous reports were inconsistent.

methodsTwo hundred seven subjects were screened for PCOS according to the diagnostic guideline of the Rotterdam consensus criterion. Serum Fetuin-A levels were measured using an ELISA kit. An independent t-test or Nonparametric test was used to detect differences between PCOS and control groups. Spearman's correlation analysis was used to examine the association of the serum Fetuin-A with other parameters.

resultsOur findings showed that circulating Fetuin-A concentration ranged from 196.6 to 418.2 μg/L for most women without PCOS (95%). Women with PCOS had higher circulating Fetuin-A levels than healthy women (437.9 ± 119.3 vs. 313.8 ± 60.5 μg/L; p <  0.01). Serum Fetuin-A was positively correlated with BMI, WHR, TG, TC, LDL-C, HOMA-IR, LH, T, and DHEA-S. Multivariate regression analysis showed that WHR, TG, HOMA-IR, and DHEA-S were independent predictors of the levels of circulating Fetuin-A. Binary logistic regression revealed that serum Fetuin-A was associated with the occurrence of PCOS. In addition, our ROC curve analysis found that the cutoff values for Fetuin-A to predict PCOS and IR were 366.3 and 412.6 μg/L.

conclusionBlood Fetuin-A may be a useful biomarker for screening women for PCOS and IR.

Indexed as

Adultalpha-2-HS-GlycoproteinBiomarkersCross-Sectional StudiesFemaleHumansInsulin ResistancePolycystic Ovary SyndromeYoung AdultAHSG protein, humanalpha-2-HS-GlycoproteinBiomarkersFetuin-aInsulin resistancePolycystic ovary syndrome

Identifiers

PMID32429902
PMCPMC7236448
OpenAlexW3026692912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.